14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:SBBP
Delisted

Strongbridge Biopharma plc Stock Signals

$2.00
+0 (+0%)
At Close: May 27, 2022

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 162 days ( 0 % )
Last Price $2.00 0 %
High/ Low $2.00 - $2.00 0%
Chg 7 Days N/A $2.00 $2.00
Chg 30 Days N/A $2.00 $2.00
Chg 12 mos -23.95 % $2.63 $2.00
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -23.64 % Width: 87.90 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $1.00 - $1.87 -50.24 % - -6.49 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Oct 18, 2021 - 155 days
Long MA avg 12 mos Buy Feb 23, 2022 - 67 days
Short/Long MA avg 12 mos Buy Feb 23, 2022 - 67 days
Pivot Short Buy May 26, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Strongbridge Biopharma plc

Strongbridge Biopharma plc Strongbridge Biopharma plc, a biopharmaceutical company, through its subsidiary, Cortendo AB (publ), develops, acquires, and commercializes product candidates that target rare diseases. The company’s lead product candidate, COR-003 (levoketoconazole), is a cortisol inhibitor that is in the Phase 3 trial for the treatment of endogenous Cushing’s syndrome. It also has two product candidates, COR-004 and COR-005 in Phase 2 clinical development to ... SBBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT